Pricing Log in Create free account

Alpha Cognition Inc. (ACOG) vs Cartesian Therapeutics, Inc. (RNAC)

Alpha Cognition Inc. and Cartesian Therapeutics, Inc. are both Biotechnology companies. Alpha Cognition Inc. and Cartesian Therapeutics, Inc. are of similar size ($191.8M and $191.7M). Cartesian Therapeutics, Inc. has the higher net margin (0.00% vs −137.7%) and the higher return on invested capital (0.00% vs −144.7%). Across the 15 metrics below, Cartesian Therapeutics, Inc. leads on 8 and Alpha Cognition Inc. on 7.

Valuation

Metric ACOG RNAC Biotechnology median
P/E n/m n/m 8.42
P/S 12.06 109.24 10.01
P/B 3.47 n/m 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 9.41 61.62 9.41
Earnings yield (12.78%) (90.12%) (31.85%)
Free cash flow yield (20.15%) (40.54%) (24.58%)

Profitability

Metric ACOG RNAC Biotechnology median
Gross margin 90.37% 100.00% 65.16%
Operating margin (174.70%) 0.00% 0.00%
Net margin (137.69%) 0.00% 0.00%
Free cash flow margin (242.99%) 0.00% 0.00%
Return on equity (49.53%) 236.88% (56.36%)
Return on assets (38.33%) (42.77%) (48.04%)
Return on invested capital (144.65%) 0.00% 0.00%

Growth

Metric ACOG RNAC Biotechnology median
Revenue growth (TTM) — (94.81%) 6.02%
EPS growth (last fiscal year) 42.08% (11.80%) 30.26%
Revenue growth, 5-year CAGR — (29.96%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACOG RNAC Biotechnology median
Debt to equity 0.00 (0.42) 0.00
Current ratio 9.03 7.48 4.72
Net debt to EBITDA 2.92 0.89 0.96

Dividend

Metric ACOG RNAC Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ACOG RNAC Biotechnology median
Market cap 191.65m 191.82m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack